About Us

Key Development and Clinical Operations Team

DEVELOPMENT

Building Design and Construction Management:

The project design is being led by Boston based Proton Concept design firm SCI.X Science Studio in cooperation with East Hartford based Architectural and Engineering firm Russell & Dawson. Principals in the two firms have collaborated on projects since the 1990s. SCI.X, led by Principal Stephen Courtney, has provided concept designs for over 27 proton therapy facilities assisting in the development of proton therapy facilities throughout the US and on several international projects including Singapore, Canada, Malaysia, Hong Kong, Thailand and most recently Cairo.

Medical Equipment:

Mevion Medical Systems will supervise the shipment, rigging and installation of their proton therapy system manufactured just outside of Boston in Littleton, Massachusetts. The main equipment element for delivery is the 20-ton accelerator module, which is the heart of the system. Our Facilities Director, Jack Harty, previously the Mevion Site Planning Coordinator for 10 years, oversees the design coordination and equipment installation process.

Bond Placement:

Investment bankers Hilltop Securities, lead by Managing Director, Steve Coma and his bond placement staff will market and secure the “A” bond offering to the institutional investors who have invested in this project type previously some of whom are: Nuveen, Invesco, Lord Abbett, Allianz/Pimco, T. Rowe Price, Blackrock, Vanguard, Dreyfus, BNY Mellon, Wells Fargo and others. Subordinated “B” bonds will be invested in by project developer SCI.D and the medical equipment manufacturer Mevion. Our bond counsel is Bryon Farnsworth in the Denver office of Norton Rose Fulbright.

CLINICAL OPERATIONS

Castle Pines Proton as an outpatient clinic will be led by a seasoned team of professionals the key members of which are outlined below:

Radiation Oncologist: Leslie Yonemoto, MD. BS, MBA

Medicine trained physician and a radiation oncologist who has trained physicians for over 20 years at proton therapy centers including Loma Linda University, Procure Oklahoma, Reinecker Proton Therapy Center and Hampton University.

  • Les has lectured and consulted on clinical, research, and operational aspects of proton therapy in many domestic and international forums and has been featured in several national and regional news programs.

  • Dr. Yonemoto also holds a BS in Electrical Engineering as well as an MBA.​

Physics Director: Michael Moyers. B.S., B.A., M.S., Ph.D., D.A.B.M.P.

  • In 1990, Dr. Moyers joined the Loma Linda University Medical Center and was a key developer of proton treatment capabilities including beam delivery, treatment planning, patient alignment, dosimetry, and expansion of patient treatment sites.

  • The holder of eight proton therapy patents, Mike is a true innovator in the field.

  • He is a prodigious contributor to industry knowledge, having co-authored industry tome Practical Implementation of Light Ion Beam Treatments and over 60 peer reviewed publications.

  • Dr. Moyers is currently Head & Senior Physicist, Division of Radiation Physics at the Shanghai Proton & Heavy Ion Center, China.

Finance Director: Don Melson

  • Mr. Melson is an experienced Chief Financial Officer with a demonstrated history of working in the medical device industry.

  • Mr. Melson most recently served five years as Vice President and Chief Financial Officer of Mevion Medical Systems, the manufacturer of Castle Pines Proton’s proton therapy equipment.

  • Prior to Mevion, he was Vice President – Corporate Controller of Analogic for six years and served as Vice President – Finance of the Millipore BioProcess Division and later as Vice President – Corporate Controller, for a total of 10 years. For Amicon, a subsidiary of W.R. Grace, Mr. Melson served as CFO.

  • Mr. Melson, a CPA (inactive), earned his undergraduate degree at Brown, an MBA at Columbia and a Certificate/Executive Program at MIT’s Sloan School of Management.